TY - JOUR T1 - Overview of Best Practices for Biopharmaceutical Technology Transfers JF - PDA Journal of Pharmaceutical Science and Technology JO - PDA J Pharm Sci Technol SP - 645 LP - 649 DO - 10.5731/pdajpst.2015.01086 VL - 69 IS - 5 AU - Sushil Abraham AU - David Bain AU - John Bowers AU - Heidi Kenty AU - Victor Larivee AU - Francisco Leira AU - Jasmina Xie AU - Jonathan Tsang Y1 - 2015/09/01 UR - http://journal.pda.org/content/69/5/645.abstract N2 - Technology transfer is a key foundational component in product commercialization. It is more than just the transfer of documents; it relates to all aspects of the transfer of knowledge and experience to the commercial manufacturing unit to ensure consistent, safe, and high-quality product. This is the first in a series of articles from the BioPhorum Operations Group (BPOG) member companies discussing best practices and benchmarking of biopharmaceutical technology transfer. In this article, we provide the common terminology developed by BPOG to accommodate both transferring and receiving organizations. We also review the key elements of a robust technology transfer business process, including critical milestones. Finally, we provide a brief overview of the articles in this series. ER -